20.04.2010 • News

Lanxess Expands Capacities for High-Tech Plastics in China

Lanxess said it will expand capacities at its plant for high-tech plastics in Wuxi, China. The German specialty chemicals company will invest in a third production line at the plant, which will increase compounding capacities by nearly 50% and is scheduled to go on stream mid-2011. After the expansion, the plant will have a capacity of approximately 60,000 mt/y.

“This investment will serve the growing demand from Chinese and Asian customers for premium, high-performance engineering plastics, mainly driven by the booming automotive industry,” said Axel C. Heitmann, Lanxess chairman of the board of management. He added that Lanxess was considering further investments in Wuxi in the near future.

Increased domestic consumption and the growing purchasing power of China’s burgeoning middle class are currently supporting the growth path of the Chinese economy. The mega-trends of mobility and urbanization are key pillars of this growth. As segments of the population shift from rural to urban areas, the result is a greater demand for automobiles and modern urban housing. As a result of this rapid development, China is now the world’s largest automotive market with unit sales projected to rise by 8% to more than 14 million vehicles in 2010. This has led to a significant increase in demand for Lanxess engineering plastics and high-performance rubbers.

Company

Logo:

LANXESS Deutschland GmbH

Kennedyplatz 1
50569 Köln
Germany

Company contact







Special Issue

Circular Plastics Economy
Explore the Future of Plastics

Circular Plastics Economy

This special CHEManager issue explores the industry’s pivotal shift towards a more sustainable, circular plastics value chain. Readers will find expert analysis and real-world solutions for today’s most pressing recycling and regulatory challenges.

Interview

Navigating Uncertainty and Driving Innovation
Meeting Pharma’s Demand for Speed, Reliability, and Flexibility

Navigating Uncertainty and Driving Innovation

Axplora CCO Arul Ramadurai discusses navigating industry uncertainty, building strategic partnerships, and advancing flexible pharmaceutical manufacturing

most read